Cassava Sciences Inc - Strategy, SWOT and Corporate Finance Report
Summary
Cassava Sciences Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Cassava Sciences Inc (Cassava Sciences or ‘the company’), formerly Pain Therapeutics Inc, is a developer of proprietary drugs for various patients and healthcare professionals. The company primarily develops drugs related to the disorders in nervous systems and are also used to treat severe chronic pain, severe pains and alzheimer's disease (AD). Cassava Sciences’ lead product candidate PTI-125 is a small molecule being developed in phase IIb clinical trials for the treatment of Alzheimer’s disease. It is also investigating SavaDx, a blood-based diagnostic for the detection of Alzheimer's disease. Cassava Sciences outsources formulation, manufacturing, and related activities to third parties through commercial supply agreements. The company is headquartered in Austin, Texas, the US
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook